BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 30923528)

  • 1. Leucocyte Trafficking via the Lymphatic Vasculature- Mechanisms and Consequences.
    Jackson DG
    Front Immunol; 2019; 10():471. PubMed ID: 30923528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell entry to lymphatic capillaries is orchestrated by CD44 and the hyaluronan glycocalyx.
    Johnson LA; Banerji S; Lagerholm BC; Jackson DG
    Life Sci Alliance; 2021 May; 4(5):. PubMed ID: 33687996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronan and Its Receptors: Key Mediators of Immune Cell Entry and Trafficking in the Lymphatic System.
    Johnson LA; Jackson DG
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling.
    Tal O; Lim HY; Gurevich I; Milo I; Shipony Z; Ng LG; Angeli V; Shakhar G
    J Exp Med; 2011 Sep; 208(10):2141-53. PubMed ID: 21930767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and Immune Function of Afferent Lymphatics and Their Mechanistic Contribution to Dendritic Cell and T Cell Trafficking.
    Arasa J; Collado-Diaz V; Halin C
    Cells; 2021 May; 10(5):. PubMed ID: 34065513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1.
    Johnson LA; Banerji S; Lawrance W; Gileadi U; Prota G; Holder KA; Roshorm YM; Hanke T; Cerundolo V; Gale NW; Jackson DG
    Nat Immunol; 2017 Jul; 18(7):762-770. PubMed ID: 28504698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan in the lymphatics: The key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking.
    Jackson DG
    Matrix Biol; 2019 May; 78-79():219-235. PubMed ID: 29425695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging leukocyte migration through afferent lymphatics.
    Collado-Diaz V; Medina-Sanchez JD; Gkountidi AO; Halin C
    Immunol Rev; 2022 Mar; 306(1):43-57. PubMed ID: 34708414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic Regulation of Cellular Trafficking.
    Jackson DG
    J Clin Cell Immunol; 2014 Oct; 5():. PubMed ID: 27808282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell traffic and the lymphatic endothelium.
    Johnson LA; Jackson DG
    Ann N Y Acad Sci; 2008; 1131():119-33. PubMed ID: 18519965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1.
    Gale NW; Prevo R; Espinosa J; Ferguson DJ; Dominguez MG; Yancopoulos GD; Thurston G; Jackson DG
    Mol Cell Biol; 2007 Jan; 27(2):595-604. PubMed ID: 17101772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses.
    Das S; Sarrou E; Podgrabinska S; Cassella M; Mungamuri SK; Feirt N; Gordon R; Nagi CS; Wang Y; Entenberg D; Condeelis J; Skobe M
    J Exp Med; 2013 Jul; 210(8):1509-28. PubMed ID: 23878309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes.
    Rantakari P; Auvinen K; Jäppinen N; Kapraali M; Valtonen J; Karikoski M; Gerke H; Iftakhar-E-Khuda I; Keuschnigg J; Umemoto E; Tohya K; Miyasaka M; Elima K; Jalkanen S; Salmi M
    Nat Immunol; 2015 Apr; 16(4):386-96. PubMed ID: 25665101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic specific disruption in the fine structure of heparan sulfate inhibits dendritic cell traffic and functional T cell responses in the lymph node.
    Yin X; Johns SC; Kim D; Mikulski Z; Salanga CL; Handel TM; Macal M; Zúñiga EI; Fuster MM
    J Immunol; 2014 Mar; 192(5):2133-42. PubMed ID: 24493818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High endothelial venules as traffic control points maintaining lymphocyte population homeostasis in lymph nodes.
    Mionnet C; Sanos SL; Mondor I; Jorquera A; Laugier JP; Germain RN; Bajénoff M
    Blood; 2011 Dec; 118(23):6115-22. PubMed ID: 21937697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium.
    Johnson LA; Clasper S; Holt AP; Lalor PF; Baban D; Jackson DG
    J Exp Med; 2006 Nov; 203(12):2763-77. PubMed ID: 17116732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils rapidly transit inflamed lymphatic vessel endothelium via integrin-dependent proteolysis and lipoxin-induced junctional retraction.
    Rigby DA; Ferguson DJ; Johnson LA; Jackson DG
    J Leukoc Biol; 2015 Dec; 98(6):897-912. PubMed ID: 26216937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different role of CD73 in leukocyte trafficking via blood and lymph vessels.
    Ålgars A; Karikoski M; Yegutkin GG; Stoitzner P; Niemelä J; Salmi M; Jalkanen S
    Blood; 2011 Apr; 117(16):4387-93. PubMed ID: 21346249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic-cell trafficking to lymph nodes through lymphatic vessels.
    Randolph GJ; Angeli V; Swartz MA
    Nat Rev Immunol; 2005 Aug; 5(8):617-28. PubMed ID: 16056255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralymphatic CCL21 Promotes Tissue Egress of Dendritic Cells through Afferent Lymphatic Vessels.
    Russo E; Teijeira A; Vaahtomeri K; Willrodt AH; Bloch JS; Nitschké M; Santambrogio L; Kerjaschki D; Sixt M; Halin C
    Cell Rep; 2016 Feb; 14(7):1723-1734. PubMed ID: 26876174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.